Evaluation of CCL18 and S100A4 as biomarkers in small cell lung cancer (SCLC) progression and response to therapy - Vienna 2024

Predictive and prognostic factors in lung cancer

Chair(s): Fernando Gamarra, Marco Nardini

Session type: Poster session

Evaluation of CCL18 and S100A4 as biomarkers in small cell lung cancer (SCLC) progression and response to therapy

Xuan Phuoc Nguyen

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

The dynamics of natural killer cell activity as a prognostic factor in patients receiving curative surgery for non-small cell lung cancer

Sara Witting Christensen Wen

Poster

Abstract

Identification of specific miRNA signatures in EBC for non-invasive lung cancer diagnosis and prognosis: A proof-of-concept study

Divyanjali Rai

Poster

Abstract

Association of sleep-related hypoxia with survival in patients with non-small cell lung cancer the NEOSAS-GFPC study group

Gr?goire Justeau

Poster

Abstract

Anti-cancer immune activation post bronchoscopic thermal ablation in non-small cell lung cancer

Kanishka Rangamuwa

Abstract

The impact of visceral pleural invasion on survival in non-small cell lung cancer

Hasan Ibis

Poster

Abstract

Assessing the Prognostic Significance of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A retrospective study

Su Yu Hua

Poster

Abstract

Selenoproteins: early biomarkers of lung cancer

Alberto Gonz?lez Hern?ndez

Poster

Abstract

Effects of the anesthesia on the overall survival and recurrence of lung cancer: meta-analysis

Omar Alomari

Poster

Abstract

Evaluation of CCL18 and S100A4 as biomarkers in small cell lung cancer (SCLC) progression and response to therapy

Xuan Phuoc Nguyen

Poster

Abstract

Clinicopathological features and prognostic factors in patients with pulmonary pleomorphic carcinoma

Baris Demirkol

Poster

Abstract

Potential predictors of immunotherapy-induced pneumonitis in non-small cell lung cancer (NSCLC)

Francesca Maria Pontoriero

Poster

Abstract

The mTORC1-related single nucleotide polymorphisms in the peripheral blood facilitate the prediction of brain metastasis of non-small cell lung cancer

Hongru Li

Poster

Abstract

MS4A15 is a novel prognostic biomarker and a potential target in lung adenocarcinoma

Lingxiao Qiu

Abstract

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with early stage non small cell lung cancer

Min-chun Chuang

Poster

Abstract

The impact of clinical features on prognosis in advanced-stage lung adenocarcinoma

Elif ?en

Ahmet Melih Sahin

Poster

Abstract

Predicting histopathological features of aggressiveness in lung cancer using CT radiomics: a systematic review

Daryl Cheng

Poster

Abstract

Endocrine toxicity as an independent predictor of response to immune checkpoint inhibitors in lung cancer patients

Andriani Charpidou

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}